## Clinical Context This patient has **asymptomatic hyperkalemia** (K⁺ 6.8 mEq/L) **without ECG changes** in the setting of acute kidney injury (AKI) and ACE inhibitor use. The absence of cardiac manifestations and symptoms allows for a **conservative, stepwise approach** rather than aggressive pharmacotherapy. ## Hyperkalemia Management: Symptomatic vs. Asymptomatic ```mermaid flowchart TD A["Hyperkalemia K+ > 6.5 mEq/L"]:::outcome A --> B{"Symptomatic or<br/>ECG changes?"}:::decision B -->|Yes| C["EMERGENCY<br/>IV Calcium gluconate<br/>Insulin + dextrose"]:::urgent B -->|No| D{"Cause reversible?"}:::decision D -->|Yes| E["Remove offending agent<br/>Dietary restriction<br/>Monitor K+"]:::action D -->|No| F["Diuretics if euvolemic<br/>Cation exchanger<br/>Consider dialysis"]:::action E --> G["Recheck in 24–48 hrs"]:::action F --> H["Ongoing management"]:::outcome ``` ## Why Conservative Management Here? **Key Point:** Asymptomatic hyperkalemia WITHOUT ECG changes can be managed conservatively. The **offending agent (lisinopril) is reversible**, and dietary potassium restriction plus monitoring is appropriate first-line. **High-Yield:** ACE inhibitors and ARBs cause hyperkalemia by **blocking aldosterone** → reduced renal potassium excretion. Discontinuation rapidly reverses this effect. ## Management Stratification | Feature | Symptomatic + ECG Changes | Asymptomatic, No ECG Changes | | --- | --- | --- | | **Urgency** | EMERGENCY (minutes) | Non-urgent (hours–days) | | **First step** | IV Calcium gluconate | Identify and remove cause | | **Second step** | Insulin + dextrose | Dietary K⁺ restriction | | **Third step** | Beta-2 agonist ± diuretics | Monitor K⁺ in 24–48 hrs | | **Dialysis** | Consider if severe/refractory | Only if persistent/worsening | ## Specific Actions for This Patient 1. **Discontinue lisinopril** — removes the primary cause of hyperkalemia in AKI 2. **Dietary potassium restriction** — avoid bananas, oranges, potatoes, tomato products 3. **Recheck serum potassium in 24–48 hours** — expect normalization with lisinopril cessation and dietary restriction 4. **Monitor urine output and renal function** — AKI may recover; if so, lisinopril can be restarted once K⁺ normalizes and eGFR improves **Clinical Pearl:** In AKI, ACE inhibitors and ARBs are often temporarily withheld until renal function stabilizes. Once creatinine returns toward baseline and potassium normalizes, they can be cautiously reintroduced. ## Why NOT the Other Options? **Warning:** Do NOT immediately start insulin + dextrose in asymptomatic hyperkalemia—this is reserved for symptomatic or ECG-positive cases. Unnecessary pharmacotherapy increases risk of hypoglycemia and hypokalemia. **Tip:** Sodium polystyrene sulfonate and dialysis are overkill for asymptomatic hyperkalemia in a reversible cause. Reserve these for refractory or life-threatening cases. [cite:Harrison 21e Ch 280; KD Tripathi 8e Ch 24]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.